Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Nintedanib shows potent antifibrotic effects in preclinical models of SSc

July 10, 2015

Scaffolds based on synthetic TCP and autologous cells for maxillofacial surgery

July 7, 2015

Xiaflex approved in Japan for Dupuytren's contracture

July 6, 2015

Taisho and Ablynx sign exclusive license agreement for ozoralizumab in Japan

July 2, 2015

Aurigene Discovery Technologies discloses RORgamma modulators

June 29, 2015

European approval of Simponi for non-radiographic axial spondyloarthritis

June 29, 2015

14-3-3eta shows potential as a drug target for the treatment of arthritis

June 26, 2015

Biotest regains rights to tregalizumab after AbbVie opts out of agreement

June 25, 2015

Guselkumab and ustekinumab do not meet primary endpoint in rheumatoid arthritis trial

June 25, 2015

3SBio acquires global rights to anti-TNF MAb

June 23, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...